Bone Pain
7
5
5
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
28.6%
2 terminated out of 7 trials
0.0%
-86.5% vs benchmark
0%
0 trials in Phase 3/4
0%
1 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (7)
Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain
Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers
Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Correlation of Timing of Pegfilgrastim Administration and PIBP.
Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use